World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
41132
World Ranking
9547
National Ranking
522

Overview

Jalid Sehouli is affiliated with Charité - University Medicine Berlin in Germany. Their research primarily spans the field of Medicine, with significant contributions to subfields such as Reproductive Medicine, Oncology, Obstetrics and Gynecology, Surgery, and Pulmonary and Respiratory Medicine.

The scientist's work covers key topics including:

  • Ovarian cancer diagnosis and treatment
  • Endometrial and Cervical Cancer Treatments
  • PARP inhibition in cancer therapy
  • Cervical Cancer and HPV Research
  • BRCA gene mutations in cancer
  • Endometriosis Research and Treatment
  • Intraperitoneal and Appendiceal Malignancies

They have published extensively in various frequent venues, notably:

  • International Journal of Gynecological Cancer
  • Journal of Clinical Oncology
  • Geburtshilfe und Frauenheilkunde
  • Cancers
  • Archives of Gynecology and Obstetrics

Prominent recent papers authored or co-authored by Jalid Sehouli include:

  • ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma, 2020, International Journal of Gynecological Cancer
  • Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39), 2021, Journal of Clinical Oncology
  • Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial, 2024, The Lancet
  • Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial, 2023, Annals of Oncology
  • Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment, 2020, The EMBO Journal

Frequent co-authors collaborating with Sehouli include:

  • Elena Ioana Braicu
  • Philipp Harter
  • Ignace Vergote
  • Pauline Wimberger
  • Felix Hilpert

Best Publications

  • A phase 3 trial of bevacizumab in ovarian cancer.

    Timothy J Perren;Ann Marie Swart;Jacobus Pfisterer;Jonathan A Ledermann

  • Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.

    Isabelle Ray-Coquard;Patricia Pautier;Sandro Pignata;David Pérol

  • ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.

    Nicole Concin;Xavier Matias-Guiu;Ignace Vergote;David Cibula

  • ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

    N. Colombo;C. Sessa;A. du Bois;J. Ledermann

  • Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse

    Eric Pujade-Lauraine;Uwe Wagner;Elisabeth Aavall-Lundqvist;Val Gebski

  • Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial

    Philipp Harter;Andreas du Bois;Maik Hahmann;Annette Hasenburg

  • A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms

    Philipp Harter;Jalid Sehouli;Domenica Lorusso;Alexander Reuss

  • Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors.

    Carsten Denkert;Jan Budczies;Tobias Kind;Wilko Weichert

  • The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids.

    Mirjana Kessler;Karen Hoffmann;Volker Brinkmann;Oliver Thieck

  • Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM.

    Steffen Runz;Sascha Keller;Christian Rupp;Alexander Stoeck;Alexander Stoeck

  • Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes

    Sascha Keller;Anne-Kathleen König;Frederik Marmé;Steffen Runz

  • Systematic review and meta-analysis of antibiotic therapy for bone and joint infections

    Dirk Stengel;Kai Bauwens;Jalid Sehouli;Axel Ekkernkamp

  • Magnetic nanoparticles for interstitial thermotherapy--feasibility, tolerance and achieved temperatures.

    Peter Wust;Uwe Gneveckow;Manfred Johannsen;Dirk Böhmer

  • Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer: The Multicenter Intergroup Study DESKTOP II. A Project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO

    Philipp Harter;Jalid Sehouli;Alexander Reuss;Annette Hasenburg

  • The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy

    L. C. Hanker;S. Loibl;N. Burchardi;J. Pfisterer

  • Contemporary management of endometrial cancer

    Jason D Wright;Nicanor I Barrena Medel;Jalid Sehouli;Keiichi Fujiwara

  • Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.

    Aurelia Noske;Wilko Weichert;Silvia Niesporek;Annika Röske

  • Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma.

    Silvia Darb-Esfahani;Catarina Alisa Kunze;Hagen Kulbe;Jalid Sehouli

  • ErbB-3 Predicts Survival in Ovarian Cancer

    Berno Tanner;Dirk Hasenclever;Katja Stern;Wiebke Schormann

  • Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39).

    Kathleen N Moore;Kathleen N Moore;Michael Bookman;Jalid Sehouli;Austin Miller

Frequent Co-Authors

Carsten Denkert
Carsten Denkert Philipp University of Marburg
Andreas du Bois
Andreas du Bois Johannes Gutenberg University of Mainz
Manfred Dietel
Manfred Dietel Charité - University Medicine Berlin
Peter Hillemanns
Peter Hillemanns Hannover Medical School
Christian Marth
Christian Marth Innsbruck Medical University
Giovanni Scambia
Giovanni Scambia Catholic University of the Sacred Heart
Wilko Weichert
Wilko Weichert Technical University of Munich
Nicoletta Colombo
Nicoletta Colombo University of Milano-Bicocca
Domenica Lorusso
Domenica Lorusso Catholic University of the Sacred Heart

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare but not sure if a traditional medical degree is right for you? There are diverse online degree and certification options that can help you start your medical career. Many students consider entering nursing as a practical choice. For those looking to switch careers without a nursing background, the cheapest direct entry msn programs offer a fast and affordable route to advanced nursing roles.

If undergraduate nursing is your path, you may want to explore what is the easiest nursing school to get into to boost your chances of acceptance and reduce application stress.

Not all healthcare careers require direct patient care. Medical coding and billing are in high demand and can be pursued fully online. Check the medical billing and coding schools online for accredited programs that also offer financial aid.

For those seeking practical nursing pathways with fewer admission barriers, some schools offer an lpn program without teas test requirements, making it easier to get started in patient care roles.

Exploring these options can help you discover the right healthcare career to match your ambitions and personal circumstances.

Best Scientists Citing Jalid Sehouli

Trending Scientists

Recently Published Articles